Prot# C-300-01: Phase II Study of AG-858 Plus Gleevec? In Patients with Chronic Myelogenous Leukemia (CML) In Chronic Phase Who Are Cytogenetically Positive After Treatment with Gleevec?

Project: Research project

Project Details

StatusFinished
Effective start/end date8/28/031/1/11

Funding

  • Agenus Inc. (C-300-01)